Chimerix Announces Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016 12:30 pm UTC| Business
- Company to hold conference call at 8:30am ET today -- Survival and other key data from AdVise and matched controls to be reviewed with regulators in Summer 2016 - DURHAM, N.C., Feb. 29, 2016 -- Chimerix, Inc....
Aehr Test Systems Announces Delivery of New FOX-XP™ Wafer Level Test and Burn-in System
Feb 29, 2016 12:30 pm UTC| Business
FREMONT, Calif., Feb. 29, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it has received customer acceptance for and delivered its first...
Feb 29, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., Feb. 29, 2016 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Cytokinetics Joins Global Movement to Recognize International Rare Disease Day
Feb 29, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that it is joining forces with the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare...
Feb 29, 2016 12:30 pm UTC| Business
NOVATO, Calif., Feb. 29, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Week, beginning February 29, 2016, with a series of activities and events that will celebrate...
Cempra to Present at the Cowen and Company 36th Annual Healthcare Conference
Feb 29, 2016 12:30 pm UTC| Business
CHAPEL HILL, N.C., Feb. 29, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...
Otonomy to Present at Cowen and Company Health Care Conference
Feb 29, 2016 12:30 pm UTC| Business
SAN DIEGO, Feb. 29, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...